InvestorsHub Logo
Followers 15
Posts 1296
Boards Moderated 0
Alias Born 11/30/2016

Re: ByMorStock post# 288

Wednesday, 10/25/2017 10:55:10 AM

Wednesday, October 25, 2017 10:55:10 AM

Post# of 864
https://sheridandaily.com/the-street-expecting-0-23-per-share-for-sangamo-therapeutics-inc-nasdaqsgmo/347791/
Zacks provides a simplified scale for analyst recommendations. They use a one to five scale where they translate brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 represents a consensus Sell rating. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) currently has an ABR of 1.67 heading into today’s announcement. This ABR has an industry rank of 173. This number is also based on the 6 sell-side firms polled by Zacks. Analysts on a consensus basis are expecting that the stock will reach $16.75 within the year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SGMO News